Description

ITRASPORAX 50 SB CAP is a broad-spectrum antifungal medication formulated with Itraconazole 50 mg in sustained-release bead (SB) capsule form. It belongs to the triazole class of antifungals and is widely used to treat dermatophytosis, onychomycosis, systemic mycoses, and fungal infections of the respiratory tract and internal organs.

The sustained-release formulation ensures prolonged antifungal activity, enhanced absorption, and consistent plasma levels, leading to better therapeutic efficacy and improved patient compliance.

Itraconazole works by inhibiting fungal cytochrome P450 enzymes, thereby blocking the synthesis of ergosterol, a critical component of fungal cell membranes.

Therapeutic Uses:

• Dermatophytosis (ringworm, athlete’s foot, jock itch)

• Fungal nail infections (onychomycosis)

• Systemic fungal infections (aspergillosis, histoplasmosis)

• Oral, esophageal, and vaginal candidiasis

• Prophylaxis in immunocompromised patients

Key Benefits:

• Sustained-release formula ensures prolonged antifungal action

• Effective against superficial and deep fungal infections

• High tissue penetration and longer duration of action

• Convenient dosing and better compliance

• Manufactured under WHO-GMP standards for global quality assurance

ITRASPORAX 50 SB CAP is produced in WHO-GMP and ISO-certified manufacturing facilities and is exported worldwide by BLUEPILL EXPRESS, a globally recognized pharmaceutical supplier. The product is available in major international markets across Asia, Africa, the Middle East, Latin America, and Europe with full export documentation, regulatory support, and private-label services.